Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jetty A M Weijers

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Applied Statistics|February 6, 2026
Bayesian federated inference for survival modelsHassan Pazira, Emanuele Massa, Jetty A M Weijers, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.
Oral Oncology|November 8, 2023
Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trialJetty A M Weijers, Tessa J J de Bitter, Gerald W Verhaegh, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Applied Statistics|February 6, 2026
Bayesian federated inference for survival modelsHassan Pazira, Emanuele Massa, Jetty A M Weijers, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.
Oral Oncology|November 8, 2023
Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trialJetty A M Weijers, Tessa J J de Bitter, Gerald W Verhaegh, et al.
Pageof 1